🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo controlled study will involve 600 he...
Status
Completed
Location
Retina Consultants of Southern Colorado
Start Date
2017-10-05
Trial ID
NCT03320174
Treatments Being Tested
This will be a randomized, single-blind, placebo controlled, parallel group...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-26
Trial ID
NCT01928914
This study is a phase 2b, placebo controlled, randomized, blinded study of ...
Status
Completed
Location
Multiple Locations
Start Date
1997-05
Trial ID
NCT02491606
Treatments Being Tested
A clinical study to assess the efficacy and safety of oral tafenoquine comp...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05947812
Treatments Being Tested
This was a placebo controlled, randomised, double-blind, double-dummy study...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT02488980
Treatments Being Tested
This was a randomised, double-blind, placebo-controlled study to compare th...
Status
Completed
Location
Multiple Locations
Start Date
1998-08
Trial ID
NCT02488902
Treatments Being Tested
This is a prospective, double-blind, double-dummy, multicenter, comparative...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-30
Trial ID
NCT02216123
Treatments Being Tested
The goal of this Phase 2b study is to examine the safety and efficacy of th...
Status
Not Yet Recruiting
Location
Asociación Civil Selva Amazónica (ACSA)
Start Date
2026-10-01
Trial ID
NCT07430592
Treatments Being Tested
This Phase II study is designed to determine whether a single 600 mg dose o...
Status
Terminated
Location
Bangkok Hospital for Tropical Diseases/Mahidol University
Start Date
2003-09-15
Trial ID
NCT01290601
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501